Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04930705 · ClinicalTrials.gov registry record · NA

Study To Assess The Safety And Efficacy Of The Tempsure Flexsure Applicators For Abdominal Wrinkles

A NA study, sponsored by Cynosure.

Terminated
Registry status
NA
Development phase
15
Enrollment target

NCT04930705: Clinical Trial NA study, sponsored by Cynosure.

NCT04930705 is a NA study that was terminated before completion, run by Cynosure. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04930705, a NA study, was terminated before completion, sponsored by Cynosure.

TERMINATED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

Subjects will be enrolled at 1 study center. Subjects may receive 5 treatments with the TempSure® device on the abdomen for wrinkles.

Primary Outcome

Blinded independent reviewers will be given pre-treatment and 30 day follow up images and will identify which image is pre-treatment, and which image was taken at the follow up. The percentage of correct images identified will be reported.

Interventions

  • DEVICE Treatment with TempSure Applicator

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-05-17
Est. Completion 2022-05-31
Phase NA
Cynosure

49 total trials

Why NCT04930705 stopped before completion

NCT04930705 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Treatment with TempSure Applicator is the first listed.

NCT04930705 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04930705 about?

NCT04930705 is a clinical study titled "Study To Assess The Safety And Efficacy Of The Tempsure Flexsure Applicators For Abdominal Wrinkles". Subjects will be enrolled at 1 study center. Subjects may receive 5 treatments with the TempSure® device on the abdomen for wrinkles.

What is the current status of trial NCT04930705?

This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2021-05-17. Estimated completion is 2022-05-31.

What interventions are being tested in trial NCT04930705?

The interventions under investigation include: Treatment with TempSure Applicator (DEVICE).

Who is sponsoring clinical trial NCT04930705?

This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04930705's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04930705, the US trial registry maintained by the National Library of Medicine. NCT04930705 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.